NCT03612414View on ClinicalTrials.gov

Efficacy of a Dietary Supplement (Aqualief®) in Xerostomic Patients

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 15, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

December 15, 2017

Conditions
Xerostomia Due to Hyposecretion of Salivary GlandpHSalivaQuality of Life
Interventions
DIETARY_SUPPLEMENT

Aqualief

Three tablets/day

DIETARY_SUPPLEMENT

Placebo

Three tablets/day

Trial Locations (1)

21100

Università degli Studi dell'Insubria, Varese

All Listed Sponsors
lead

Università degli Studi dell'Insubria

OTHER

NCT03612414 - Efficacy of a Dietary Supplement (Aqualief®) in Xerostomic Patients | Biotech Hunter | Biotech Hunter